Literature DB >> 30125757

Retrospective analysis of 36 fusion genes in 2479 Chinese patients of de novo acute lymphoblastic leukemia.

Xue Chen1, Fang Wang1, Yang Zhang1, Mangju Wang2, Wenjun Tian3, Wen Teng1, Xiaoli Ma1, Lei Guo1, Jiancheng Fang1, Ying Zhang2, Ping Zhu2, Hongxing Liu4.   

Abstract

Fusion genes are major molecular biological abnormalities in hematological malignancies. To depict the common recurrent gene-fusion landscape in acute lymphoblastic leukemia (ALL), 36 recurrent fusion genes in hematologic malignancies were assessed using multiplex-nested RT-PCR in 2479 patients with de novo ALL. 17 kinds of distinct fusion genes were detected in 712 (28.72%) cases. Co-occurrence of different fusion genes was observed in 6 (0.24%) patients. Incidence of fusion genes in B-ALL was significantly higher than in T-ALL (31.40% vs. 14.50%, P < 0.001). Pediatric ALL had higher prevalence of ETV6-RUNX1, TCF3-PBX1, and STIL-TAL1, while BCR-ABL1 and SET-NUP214 were more common in adult ALL. BCR-ABL1, TCF3-PBX1, KMT2A-AFF1 and ETV6-RUNX1 were more frequent in B-ALL. On the contrary, KMT2A-MLLT4, SET-NUP214 and STIL-TAL1 were of higher incidence in T-ALL. In comparison with Western cohorts, the incidence of BCR-ABL1 (5.94%) was much higher in our series, while the occurrence of ETV6-RUNX1 (13.19%) was significantly lower in pediatric B-ALL patients in our study than in Western reports. This study provides a genetic landscape of common fusion genes in ALL patients and may serve as a foundation for further improvement of a fusion gene screening panel for clinical applications.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Adult; Fusion genes; Pediatric

Mesh:

Substances:

Year:  2018        PMID: 30125757     DOI: 10.1016/j.leukres.2018.08.009

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  5 in total

1.  SET-CAN Fusion Gene in Acute Leukemia and Myeloid Neoplasms: Report of Three Cases and a Literature Review.

Authors:  Heyang Zhang; Lijun Zhang; Yan Li; Hongcang Gu; Xiaoxue Wang
Journal:  Onco Targets Ther       Date:  2020-08-03       Impact factor: 4.147

2.  Identification of RNPC3 as a novel JAK2 fusion partner gene in B-acute lymphoblastic leukemia refractory to combination therapy including ruxolitinib.

Authors:  Xue Chen; Fang Wang; Yang Zhang; Xiaoli Ma; Mingyue Liu; Panxiang Cao; Lin Zhou; Lan Wang; Xian Zhang; Tong Wang; Hongxing Liu
Journal:  Mol Genet Genomic Med       Date:  2019-12-30       Impact factor: 2.183

3.  Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With SET-CAN/NUP214 Fusion: Perspectives From a Case Report and Literature Review.

Authors:  Na Lin; Zhenghua Liu; Yan Li; Xiaojing Yan; Lei Wang
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

4.  Fusion gene map of acute leukemia revealed by transcriptome sequencing of a consecutive cohort of 1000 cases in a single center.

Authors:  Xue Chen; Fang Wang; Yang Zhang; Xiaoli Ma; Panxiang Cao; Lili Yuan; Lan Wang; Jiaqi Chen; Xiaosu Zhou; Qisheng Wu; Ming Liu; David Jin; Hongxing Liu
Journal:  Blood Cancer J       Date:  2021-06-16       Impact factor: 11.037

5.  Observation of the molecular genetics among children with acute lymphoblastic leukemia: A retrospective study based on the SEER database.

Authors:  Ying Sun; Sili Long; Wenjun Liu
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.